Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Large Cell Lymphoma
Clinical trial NCT00005631 · COMPLETED
Trial details
- NCT number
- NCT00005631
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1999-11-01
- Primary completion
- 2002-11-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.